“michael-gilman” Archives

in
Entry Author Date Location
Xconomy Awards Boston 2019 Honors Best in Life Sciences: Slideshow 10/23/19 Boston
Xconomy Awards: Gilman & Bosley to Emcee Life Science Gala in Boston 06/20/19 Boston
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More 04/19/19 National
It’s Tough to Find Drugs to Bind to RNA: Arrakis Nabs $75M to Help 04/18/19 Boston
Nominations Are Open for the 2019 Xconomy Awards in Boston 03/13/19 Boston
Pursuing a “Crazy, Stupid” Idea & Photos From Disruptors in Boston 10/25/18 Boston
Catch CRISPR 2.0, RNA-Targeting Drugs & More At “Disruptors” on Oct. 17 09/26/18 Boston
Agenda Posted for Boston’s Life Science Disruptors on Oct. 17 09/10/18 Boston
Beam, Celsius & Arrakis at Boston’s Life Science Disruptors Oct. 17 08/27/18 Boston
Bio Roundup: Trials to Watch, Mega Deals, Video Game Therapy & More 12/08/17 Boston
Gilman’s Next CEO Trick: Taming CAR-T Cells With Obsidian 12/06/17 Boston
Stifling Immigration Is “Retrograde”: Highlights From “What’s Hot” 05/17/17 Boston
Check Out What’s Hot in Boston Biotech on May 11: Saver Rate Ends Today 04/06/17 Boston
Bio Roundup: Healthcare Is Hard, “Slow” FDA, Drugging RNA & More 03/03/17 National
At Arrakis, Gilman Teams With Biogen Vets to Target RNA With Pills 02/27/17 Boston
Trump’s Election Stunner: Tech and Life Sciences Leaders React 11/09/16 National
East Coast Biotech Roundup: Harvard’s Haul, Patent Fights, Padlock & More 03/24/16 Boston
Gilman Scores for Atlas Again as Bristol Buys Padlock for up to $600M 03/23/16 Boston
Ragan Reunites Ex-Genzymers at X4 Pharma to Battle Cancer 09/01/15 Boston
East Coast Biotech Roundup: Seres, Editas, PureTech, Pronutria & More 05/29/15 Boston
From Iceland to White House, Precision Medicine’s Promises & Hurdles 03/31/15 National
East Coast Biotech Roundup: Yumanity, Padlock, CAR-T Fever, & More 12/19/14 Boston
Déjà Vu For Gilman as New Immunology Startup, Padlock, Gets $23M 12/18/14 Boston
With $24M and Pharma Backing, Ex Epizyme Prez Aims to “Raze” Tumors 10/14/14 Boston
Scholar Rock’s Local Approach to Immune Disease Nabs $20M 09/15/14 Boston
Roche To Pay $8.3B For Intermune: Who’s Next In Pulmonary Fibrosis? 08/25/14 San Francisco
East Coast Biotech Roundup: Scholar Rock, Dicerna, Eleven, & More 01/03/14 Boston
Scholar Rock Aims to Hit Disease-Causing Proteins in a “Niche” 01/02/14 Boston
East Coast Biotech Roundup: Moderna, Aileron, Seres, & More 11/22/13 Boston
Don’t Be Naïve: 7 Things to Know Before Taking a Biotech Startup Job 09/16/13 National
Page 1 of 2 next page »